Cal Budget Center Publishes Definitive Bilingual Timeline of All Medi-Cal + CalFresh Cuts — Primary Planning Resource for FQHCs
The California Budget Center published a bilingual timeline mapping every eligibility deadline, enrollment freeze date, and administrative burden change to a calendar date — quantifying up to 2 million Californians losing Medi-Cal coverage and $2.3B–$5.1B in annual federal losses. The Spanish-language version makes it directly useful for FQHC patient navigators and community outreach staff.
Key takeaways
- Use this bilingual timeline for board presentations, staff briefings, and patient navigation training — every cut mapped to a calendar date
- Spanish version available: calbudgetcenter.org/resources/cronologia-de-los-recortes-de-financiamiento-a-medi-cal-y-calfresh-en-california/
Primary source
California Budget CenterSource packet
This story's primary source + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — subscribes you to the weekly Intel Brief. Individual sources are always clickable above, no email needed.
FQHC Talent. (2026, January 15). Cal Budget Center Publishes Definitive Bilingual Timeline of All Medi-Cal + CalFresh Cuts — Primary Planning Resource for FQHCs. Primary source: California Budget Center. Retrieved July 28, 2026, from https://www.fqhctalent.com/intel/cal-budget-center-bilingual-medicaid-calfresh-timeline
More in Legislation
Jul 24
HHS strips disparate-impact liability out of its Title VI regulations — final rule, effective the day it published, no comment period; 45 CFR part 80 binds every Section 330 grantee
Jul 22
Arkansas AG sues 13 drugmakers + a data firm over 340B — the first time a state goes on OFFENSE under its own 340B shield law, with the state health-center association standing beside him
Jul 16
CY2027 Physician Fee Schedule Proposed Rule Lands — CMS Proposes the FQHC PPS Base Rate Rise to $212.91 (+2.5%), Comments Close September 14
Jul 1
8th Circuit Rejects Novartis's Bid to Block Missouri's 340B Contract-Pharmacy Law — Another State Shield Survives a Manufacturer Challenge